Campbell & Co. Investment Adviser »

Adma Biologics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $946k 65k 14.66
2025-03-31 $1.8M 90k 19.84
2024-12-31 $770k 45k 17.15
2024-09-30 $1.2M 59k 19.99
2024-03-31 $1.5M 232k 6.60
2023-09-30 $431k 120k 3.58

More positions owned by Campbell & Co. Investment Adviser

Itt Common Stock (ITT)
Cheniere Energy Common Stock (LNG)
United Rentals Common Stock (URI)
BHP Group Adr (BHP)
Cullen/Frost Bankers Common Stock (CFR)
Pool Corp Common Stock (POOL)
Ameris Bancorp Common Stock (ABCB)
Bank of America Corp Common Stock (BAC)
Aecom Common Stock (ACM)
Associated Banc-Corp Common Stock (ASB)
DTE Energy Common Stock (DTE)
Netflix Common Stock (NFLX)
Allstate Corp/The Common Stock (ALL)
Labcorp Holdings Common Stock (LH)
Southwest Airlines Common Stock (LUV)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Westfield Capital Management Company
Capital Research Global Investors
Nuveen
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
UBS Group
Thrivent Financial for Lutherans
Citadel Advisors
Caligan Partners

View all funds holding Adma Biologics